Deyu Qin, Guangxin Liu, Jing Zhang, Shanshan Lin, Xinmeng Liu, Jingxiang Zhao, Qian Zhang, Mei Ma, Shusen Wang
{"title":"创新心脏康复:适应性体位平衡运动对冠状动脉疾病和2型糖尿病的影响","authors":"Deyu Qin, Guangxin Liu, Jing Zhang, Shanshan Lin, Xinmeng Liu, Jingxiang Zhao, Qian Zhang, Mei Ma, Shusen Wang","doi":"10.2147/DMSO.S506870","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the effects of Adaptive Postural Balance Cardiac Rehabilitation Exercise (APBCRE) on glycolipid metabolism and exercise endurance in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). Specifically, we compared the efficacy of APBCRE with aerobic exercise (AE) alone and irregular exercise (IE).</p><p><strong>Patients and methods: </strong>This randomized controlled trial included 348 patients with CAD, comprising 261 patients with T2DM and 87 non-diabetic CAD patients as a control group. Participants were randomly assigned to one of four groups: the APBCRE group, the AE group, the IE group, or the non-diabetic AE control group. The intervention lasted 8 weeks, including a structured 6-week training phase. Metabolic markers and exercise endurance were assessed at baseline (week 1) and post-intervention (week 8). Cardiopulmonary exercise testing (CPET) was utilized to individualize exercise prescriptions and optimize intervention intensity.</p><p><strong>Results: </strong>The APBCRE group demonstrated significant improvements in fasting blood glucose (FBG) (-11.34%, from 7.89 to 6.99 mmol/L, p < 0.05), HbA1c (-8.87%, from 7.20% to 6.56%, <i>p</i> < 0.05), and LDL-C levels (-12.21%, from 2.44 to 2.14 mmol/L, <i>p</i> < 0.05) compared to the AE and IE groups. While both APBCRE and AE improved lipid profiles, APBCRE demonstrated superior enhancements in exercise endurance, with <i>˙VO</i> <sub>2</sub> max increasing by 18.71% (from 14.19 to 16.86 mL/min/kg, <i>p</i> < 0.05) and AT <i>˙VO</i> <sub>2</sub> increasing by 16.00% (from 11.62 to 13.48 mL/min/kg, <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>These findings support the efficacy of APBCRE in improving glycolipid metabolism, exercise endurance, and neuromuscular coordination in patients with CAD and T2DM compared to AE alone.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"1239-1254"},"PeriodicalIF":2.8000,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042206/pdf/","citationCount":"0","resultStr":"{\"title\":\"Innovative Cardiac Rehabilitation: Effects of Adaptive Postural Balance Exercise on Coronary Artery Disease and Type 2 Diabetes.\",\"authors\":\"Deyu Qin, Guangxin Liu, Jing Zhang, Shanshan Lin, Xinmeng Liu, Jingxiang Zhao, Qian Zhang, Mei Ma, Shusen Wang\",\"doi\":\"10.2147/DMSO.S506870\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aimed to evaluate the effects of Adaptive Postural Balance Cardiac Rehabilitation Exercise (APBCRE) on glycolipid metabolism and exercise endurance in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). Specifically, we compared the efficacy of APBCRE with aerobic exercise (AE) alone and irregular exercise (IE).</p><p><strong>Patients and methods: </strong>This randomized controlled trial included 348 patients with CAD, comprising 261 patients with T2DM and 87 non-diabetic CAD patients as a control group. Participants were randomly assigned to one of four groups: the APBCRE group, the AE group, the IE group, or the non-diabetic AE control group. The intervention lasted 8 weeks, including a structured 6-week training phase. Metabolic markers and exercise endurance were assessed at baseline (week 1) and post-intervention (week 8). Cardiopulmonary exercise testing (CPET) was utilized to individualize exercise prescriptions and optimize intervention intensity.</p><p><strong>Results: </strong>The APBCRE group demonstrated significant improvements in fasting blood glucose (FBG) (-11.34%, from 7.89 to 6.99 mmol/L, p < 0.05), HbA1c (-8.87%, from 7.20% to 6.56%, <i>p</i> < 0.05), and LDL-C levels (-12.21%, from 2.44 to 2.14 mmol/L, <i>p</i> < 0.05) compared to the AE and IE groups. While both APBCRE and AE improved lipid profiles, APBCRE demonstrated superior enhancements in exercise endurance, with <i>˙VO</i> <sub>2</sub> max increasing by 18.71% (from 14.19 to 16.86 mL/min/kg, <i>p</i> < 0.05) and AT <i>˙VO</i> <sub>2</sub> increasing by 16.00% (from 11.62 to 13.48 mL/min/kg, <i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>These findings support the efficacy of APBCRE in improving glycolipid metabolism, exercise endurance, and neuromuscular coordination in patients with CAD and T2DM compared to AE alone.</p>\",\"PeriodicalId\":11116,\"journal\":{\"name\":\"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy\",\"volume\":\"18 \",\"pages\":\"1239-1254\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-04-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042206/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/DMSO.S506870\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S506870","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究旨在评价适应性体位平衡心脏康复训练(APBCRE)对冠心病(CAD)合并2型糖尿病(T2DM)患者糖脂代谢和运动耐力的影响。具体来说,我们比较了APBCRE与单独有氧运动(AE)和不规则运动(IE)的疗效。患者和方法:本随机对照试验纳入348例CAD患者,其中T2DM患者261例,非糖尿病性CAD患者87例为对照组。参与者被随机分配到四组中的一组:APBCRE组、AE组、IE组或非糖尿病AE对照组。干预持续8周,包括一个为期6周的结构化训练阶段。代谢指标和运动耐力在基线(第1周)和干预后(第8周)进行评估。运用心肺运动试验(CPET)对运动处方进行个性化设计,优化干预强度。结果:与AE组和IE组相比,APBCRE组空腹血糖(FBG)(-11.34%,从7.89降至6.99 mmol/L, p < 0.05)、糖化血红蛋白(-8.87%,从7.20%降至6.56%,p < 0.05)和LDL-C水平(-12.21%,从2.44降至2.14 mmol/L, p < 0.05)均有显著改善。虽然APBCRE和AE均能改善脂质谱,但APBCRE表现出更强的运动耐力增强,˙vo2 max提高了18.71%(从14.19 mL/min/kg提高到16.86 mL/min/kg, p < 0.05), AT˙vo2提高了16.00%(从11.62 mL/min/kg提高到13.48 mL/min/kg, p < 0.05)。结论:与AE单独相比,这些发现支持APBCRE在改善CAD和T2DM患者的糖脂代谢、运动耐力和神经肌肉协调方面的疗效。
Innovative Cardiac Rehabilitation: Effects of Adaptive Postural Balance Exercise on Coronary Artery Disease and Type 2 Diabetes.
Purpose: This study aimed to evaluate the effects of Adaptive Postural Balance Cardiac Rehabilitation Exercise (APBCRE) on glycolipid metabolism and exercise endurance in patients with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). Specifically, we compared the efficacy of APBCRE with aerobic exercise (AE) alone and irregular exercise (IE).
Patients and methods: This randomized controlled trial included 348 patients with CAD, comprising 261 patients with T2DM and 87 non-diabetic CAD patients as a control group. Participants were randomly assigned to one of four groups: the APBCRE group, the AE group, the IE group, or the non-diabetic AE control group. The intervention lasted 8 weeks, including a structured 6-week training phase. Metabolic markers and exercise endurance were assessed at baseline (week 1) and post-intervention (week 8). Cardiopulmonary exercise testing (CPET) was utilized to individualize exercise prescriptions and optimize intervention intensity.
Results: The APBCRE group demonstrated significant improvements in fasting blood glucose (FBG) (-11.34%, from 7.89 to 6.99 mmol/L, p < 0.05), HbA1c (-8.87%, from 7.20% to 6.56%, p < 0.05), and LDL-C levels (-12.21%, from 2.44 to 2.14 mmol/L, p < 0.05) compared to the AE and IE groups. While both APBCRE and AE improved lipid profiles, APBCRE demonstrated superior enhancements in exercise endurance, with ˙VO2 max increasing by 18.71% (from 14.19 to 16.86 mL/min/kg, p < 0.05) and AT ˙VO2 increasing by 16.00% (from 11.62 to 13.48 mL/min/kg, p < 0.05).
Conclusion: These findings support the efficacy of APBCRE in improving glycolipid metabolism, exercise endurance, and neuromuscular coordination in patients with CAD and T2DM compared to AE alone.
期刊介绍:
An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.